Health Affairs December 17, 2025
Beginning January 1, 2026, UnitedHealthcare (UHC), the country’s largest health insurer, will limit reimbursement for remote patient monitoring (RPM) to just two conditions: heart failure and hypertensive disorders of pregnancy. For all other uses, including hypertension and diabetes, UHC now deems RPM “unproven and not medically necessary due to insufficient evidence.”
This conclusion is at odds with the weight of scientific evidence, clinical guidelines, federal policy direction, and years of real-world experience clearly showing that RPM is a well-validated technology. RPM has a robust and growing evidence-base supporting its use, particularly in hypertension management when implemented within structured, team-based care. Eliminating this coverage risks reversing gains in cardiovascular disease prevention and care for all adults.
RPM Is Effective And Evidence-Based
...Today's Sponsors
Today's Sponsor